Ependymoma, Recurrent Active Not Recruiting Phase 1 Trials for Trametinib (DB08911)

Also known as: Ependymoma Recurrent / Recurrent Ependymoma

IndicationStatusPhase
DBCOND0106575 (Ependymoma, Recurrent)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs